Full-Time

Senior Director

Strategic Product Planning, Rare Disease

Confirmed live in the last 24 hours

Acadia Pharmaceuticals

Acadia Pharmaceuticals

501-1,000 employees

Develops therapies for neurological disorders

Biotechnology
Healthcare

Compensation Overview

$217k - $271.2kAnnually

+ Bonus + Equity Awards

Senior, Expert

San Diego, CA, USA

Hybrid model requires in-office presence three days per week on average.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Market Research
Marketing
Requirements
  • Bachelor’s degree in marketing, health care, business administration or related field; MBA or advanced degree.
  • Targeting 12 years of progressively responsible experience within the pharmaceutical or biotech industry.
  • Requires 5 years’ experience working in rare disease with key internal stakeholders to develop and preparing market for launch.
  • Therapeutic areas such as Neurology, Neuroendocrine, Neuromuscular experience a plus.
  • Robust new product planning experience in early, mid and late stage programs, preferably including rare disease with ability to apply learnings to strategy and drug development.
  • Commercialization and business development collaboration experience preferred.
  • Strong interpersonal, partnering and cross-functional collaboration skills.
  • Ability to work successfully in a dynamic, fast paced, team-oriented environment with learning agility and style flexibility.
  • Ability to work with leadership and other cross functional peers and colleagues.
  • Proficiency at creating and communicating a clear vision among team members, effectively aligning resources and activities to achieve functional area and/or organizational goals.
  • Ability to challenge the status quo and drive organizational action.
  • Ability to creatively problem solve.
  • Ability to travel up to 30% of time.
Responsibilities
  • Develops the long-range commercial launch plan for the U.S. and other key global markets.
  • Lead commercial strategy for Phase 3 pipeline products, including audience definition and segmentation, value proposition, branding, positioning, and key messaging.
  • Manages productive external relationships with Key Opinion Leaders and Congress leadership.
  • Works with Access & Reimbursement, Medical Affairs and HEOR to develop differentiation, as well as effective strategies and tactics designed to secure appropriate market access for investigational disease products in the portfolio.
  • Engages with in-line functional departments (Market Access, Patient Services, Marketing and Patient Advocacy) to identify and address key areas of need and to ensure optimal level of engagement and support for the relevant patient and caregiver communities.
  • Develop analysis of target markets to determine current and future treatment paradigms, competitive landscape, unmet need, product positioning and value proposition, making commercial judgements around implications.
  • Drive development of and maintenance of strategic target product profiles (TPPs) for pipeline assets in conjunction with program teams.
  • Provides strategic direction on market research objectives, designs and interpretation to Inform asset strategies.
  • Informs the long range commercialization plan for potential new assets, particularly as it relates to resource needs and overall market opportunity (i.e. sales force sizing requirements, identification of target patient populations, HCPs, access strategy).
  • Identifies, analyzes, and translates relevant clinical and landscape data, as well as competitive intelligence, to inform the development of asset strategies and BD opportunities.
  • Conducts market/commercial assessment, including forecasts, for BD opportunities with a focus on rare opportunities based on market research, secondary research, and internal subject matter expert collaboration.
  • Assumes program/brand budget accountability for strategic product planning/commercial activities and manages spend forecasts.
  • Other duties as required.
Acadia Pharmaceuticals

Acadia Pharmaceuticals

View

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Company Stage

Acquired

Total Funding

$813.4M

Headquarters

Dallas, Texas

Founded

1993

Simplify Jobs

Simplify's Take

What believers are saying

  • Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.
  • Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.
  • The rise of personalized medicine aligns with Acadia's targeted therapy approach.

What critics are saying

  • Increased competition in CNS drug market may impact Acadia's market share.
  • Potential clinical trial delays could affect drug approval timelines.
  • Dependence on partnerships poses risks if collaborations face challenges or dissolve.

What makes Acadia Pharmaceuticals unique

  • Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.
  • The company has a strong R&D foundation, developing innovative small molecule drugs.
  • Acadia's strategic partnerships enhance its research capabilities and market reach.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement